Clinical Trials Browser

Phase 1 × Neuroblastoma × Genetic Engineering × Clear all

NCT00186862 2008-06-03

Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma

Phase 1 Completed

Neuroblastoma